Use of Telemonitoring to Facilitate Heart Failure Medication Titration
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 108 participants.
Also called NCT04205513
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 108 participants
- Registry
-
NCT04205513
-
- Other papers using this trial's data
- Carbon and Travel Cost Reduction From Remote Medication Titration for Advanced Heart Failure: A Secondary Analysis of a Randomized Controlled Trial
- The Effect of Using a Remote Patient Management Platform in Optimizing Guideline-Directed Medical Therapy in Heart Failure Patients: A Randomized Controlled Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Unknown status
Technical summary
Registry record NCT04205513. Randomized; no masking; primary purpose treatment. Start 2019-01-01 (actual); primary completion 2022-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Use of Telemonitoring to Facilitate Heart Failure Medication Titration
- Acronym
- Medly Titrate
- Condition
- Heart Failure
- Intervention (Device)
- Medly
- Lead sponsor
- University Health Network, Toronto
Record details
- Record id
cardio:ct-nct04205513- Content hash
81d26c6e2fb3c5e24e594cb2f90f08ad9c86fe5c10d17eaaa12e79b6581111fb